Thus, the aim of this study was to explore whether miR-4429 was related to EGFR, measure the expression of miR-4429 in NSCLC, investigate its clinical value in NSCLC, and explore its relationship with EGFR mutation in NSCLC patients. Here, EGFR is linked to non-small cell lung carcinoma.